Protein kinase C β1 overexpression augments phorbol ester‐induced increase in endothelial permeability

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Cellular Physiology

• Publication date

  1996-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-4652(199602)166:2<249::AID-JCP2>3.0.CO;2-PPMID 8591984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of vascular endothelial barrier function.

  1994cited by this paper
• Thrombin receptor peptide inhibits thrombin-induced increase in endothelial permeability by receptor desensitization

  1993cited by this paper
• Selective regulation of expression of protein kinase C beta isoenzymes occurs via alternative splicing.

  1993cited by this paper
• Protein kinase C phosphorylates caldesmon77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers

  1992cited by this paper
• Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increase in endothelial permeability.

  1992cited by this paper
• Time course of thrombin-induced increase in endothelial permeability: relationship to Ca2+i and inositol polyphosphates.

  1992cited by this paper
• Activation of phospholipase D by protein kinase C. Evidence for a phosphorylation-independent mechanism.

  1992cited by this paper
• Translocation of protein kinase C isozymes in thrombin-stimulated human platelets. Correlation with 1,2-diacylglycerol levels.

  1992cited by this paper
• HMEC-1: establishment of an immortalized human microvascular endothelial cell line.

  1992cited by this paper
• Dissociation of protein kinase C redistribution from the phosphorylation of its substrates.

  1991cited by this paper
• Cytoskeletal reorganizations responsible for the phorbol ester-induced formation of cytoplasmic processes: possible involvement of intermediate filaments.

  1990cited by this paper
• Increased endothelial albumin permeability mediated by protein kinase C activation.

  1990cited by this paper
• Propagation of electromagnetic waves of crossroads with a reflector inside a tunnel

  1989cited by this paper
• Protein kinase inhibitor prevents pulmonary edema in response to H2O2.

  1989cited by this paper
• Improved retroviral vectors for gene transfer and expression.

  1989cited by this paper
• The role of phosphorylation and limited proteolytic cleavage of talin and vinculin in the disruption of focal adhesion integrity.

  1989cited by this paper
• Interleukin 1 release by human alveolar macrophages and blood monocytes.

  1989cited by this paper
• Calcium dependence of the thrombin-induced increase in endothelial albumin permeability.

  1989cited by this paper
• Improved Retroviral Vectors for Gene Transfer and Expression

  1989cited by this paper
• Caldesmon: A common actin‐linked regulatory protein in the smooth muscle and nonmuscle contractile system

  1988cited by this paper
• Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton.

  1988cited by this paper
• Molecular sieving characteristics of the cultured endothelial monolayer

  1987cited by this paper
• Measurement of albumin permeability across endothelial monolayers in vitro.

  1987cited by this paper
• Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

  1986cited by this paper
• Effects of tumor promoters on LLC-PK1 renal epithelial tight junctions and transepithelial fluxes.

  1986cited by this paper
• Tumor promoter-induced disruption of junctional complexes in cultured epithelial cells is followed by the inhibition of cytokeratin and desmoplakin synthesis.

  1986cited by this paper
• Cloning and expression of multiple protein kinase C cDNAs.

  1986cited by this paper
• A tumor promoter induces rapid and coordinated reorganization of actin and vinculin in cultured cells

  1984cited by this paper
• Vinculin, a cytoskeletal substrate of protein kinase C.

  1983cited by this paper
• Immunoelectron microscope studies of membrane-microfilament interactions: distributions of alpha-actinin, tropomyosin, and vinculin in intestinal epithelial brush border and chicken gizzard smooth muscle cells

  1981cited by this paper
• Tumor promoter-induced changes in the permeability of epithelial cell tight junctions.

  1981cited by this paper
• EFFICIENT LABELLING OF SERUM PROTEINS WITH I-131 USING CHLORAMINE T.

  1964cited by this paper

• Downregulation of S1P Lyase Improves Barrier Function in Human Cerebral Microvascular Endothelial Cells Following an Inflammatory Challenge

  2020cites this paper
• Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy

  2018cites this paper
• Optimising intratumoural treatment of head and neck squamous cell carcinoma mouse models with EBC-46

  2015cites this paper
• Genetics of diabetes complications

  2014cites this paper
• Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models

  2014cites this paper
• CURRENT INDIAN EYE RESEARCH 3 Pathogenesis and Management of Diabetic Macular Edema

  2014cites this paper
• Endothelial cell signalling of APC and thrombin : the involvement of protein kinase C

  2013cites this paper
• Chapter 46 – Diabetic Retinopathy: Genetics and Etiologic Mechanisms

  2013cites this paper
• Protein Kinase C and Acute Respiratory Distress Syndrome

  2013cites this paper
• The characterization of arachnoid cell transport II: paracellular transport and blood-cerebrospinal fluid barrier formation.

  2012cites this paper
• Interplay between FAK, PKCδ, and p190RhoGAP in the regulation of endothelial barrier function.

  2012cites this paper
• Retinopathy in diabetes.

  2012cites this paper
• The egress of fluid from the brain via arachnoid transport: foundational work for the tissue engineering of the arachnoid granulation

  2011cites this paper
• Vascular endothelial growth factor-induced permeability in the pathogenesis of cardiac allograft vasculopathy

  2011cites this paper
• Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process

  2010cites this paper
• GLUCOSE AS A CARDIOVASCULAR COMPLICATIONS - OVERVIEW

  2010cites this paper
• The Impact of Macrophage Insulin Resistance on Advanced Atherosclerotic Plaque Progression [2010;106:58–67] The RAGE Axis: A Fundamental Mechanism Signaling Danger to the Vulnerable Vasculature [2010;106:842–853] The Promise of Cell-Based Therapies for Diabetic Complications: Challenges and Solution

  2010cites this paper
• Diabetic retinopathy and public health

  2010cites this paper
• Activation of protein kinase C isoforms and its impact on diabetic complications.

  2010cites this paper
• Role of protein kinase C in diabetic complications

  2010cites this paper
• Vitreous traction and epiretinal membranes in diabetic macular oedema using spectral-domain optical coherence tomography

  2010cites this paper
• Vascular Endothelial Growth Factors In Eye Diseases Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis

  2009cites this paper
• Diabetic macular edema: pathogenesis and treatment.

  2009cites this paper
• Diabetic retinopathy: An update

  2008cites this paper
• Regulation of Endothelial Junctional Permeability

  2008cites this paper
• The Role of Protein Kinase C in Diabetic Retinal Vascular Abnormalities

  2008cites this paper
• Counter Regulatory Effects of PKCβII and PKCΔ on Coronary Endothelial Permeability

  2008cites this paper
• The role of protein kinase C activation and the vascular complications of diabetes.

  2007cites this paper
• Pharmacologic therapies for diabetic retinopathy and diabetic macular edema

  2007cites this paper
• Differential recruitment of PKC isoforms in HeLa cells during redox stress

  2007cites this paper
• Role of sodium arsenite in atherogenesis

  2007cites this paper
• Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats.

  2007cites this paper
• Rottlerin causes pulmonary edema in vivo: a possible role for PKCdelta.

  2007cites this paper
• Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients.

  2006cites this paper
• Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.

  2006cites this paper
• Adipose‐specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARγ agonist's effects on edema and weight gain

  2006cites this paper
• Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation : novel mechanism for PPAR agonist ’ s effects on edema and weight gain

  2006cites this paper
• VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.

  2006cites this paper
• Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk.

  2005cites this paper
• Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.

  2005cites this paper
• Synthesis and isozyme selectivity of small molecule protein kinase C inhibitors: a review of patents

  2005cites this paper
• Effects of Diabetes and Insulin Resistance on Endothelial Functions

  2005cites this paper
• Current and future pharmacological intervention for diabetic retinopathy

  2005cites this paper
• A Vascular Gene Trap Screen Defines RasGRP3 as an Angiogenesis-Regulated Gene Required for the Endothelial Response to Phorbol Esters

  2004cites this paper
• Regulation of tight junctions and loss of barrier function in pathophysiology.

  2004cites this paper
• Protein kinase C-beta inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro.

  2004cites this paper
• Pharmacotherapy for diabetic retinopathy

  2004cites this paper
• Opposing effect of angiopoietin‐1 on VEGF‐mediated disruption of endothelial cell–cell interactions requires activation of PKCβ

  2004cites this paper
• Current approaches and perspectives in the medical treatment of diabetic retinopathy.

  2004cites this paper
• The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy

  2004cites this paper
• Therapeutic potential of natural compounds that regulate the activity of protein kinase C.

  2004cites this paper
• Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury.

  2003cites this paper
• Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

  2003cites this paper
• Role of protein kinase C isoforms in rat epididymal microvascular endothelial barrier function.

  2003cites this paper
• Diabetic Retinopathy and Diabetic

  2003cites this paper
• Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies

  2003cites this paper
• Protein kinase C-alpha activation by phorbol ester induces secretion of gelatinase B/MMP-9 through ERK 1/2 pathway in capillary endothelial cells.

  2003cites this paper
• Retinal metabolic abnormalities in diabetic mouse: Comparison with diabetic rat

  2002cites this paper
• Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.

  2002cites this paper
• Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.

  2002cites this paper
• Molecular understanding of hyperglycemia's adverse effects for diabetic complications.

  2002cites this paper
• Divergence of Angiogenic and Vascular Permeability Signaling by VEGF: Inhibition of Protein Kinase C Suppresses VEGF-Induced Angiogenesis, but Promotes VEGF-Induced, NO-Dependent Vascular Permeability

  2002cites this paper
• Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway.

  2002cites this paper
• Protein kinase signaling in the modulation of microvascular permeability.

  2002cites this paper
• Particle-Mediated Intravascular Delivery of Oligonucleotides to Tumors: Associated Biology and Lessons from Genotherapy

  2001cites this paper
• Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.

  2001cites this paper
• Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction.

  2001cites this paper
• Protein kinase C and the development of diabetic vascular complications

  2001cites this paper
• Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes

  2001cites this paper
• Serine/threonine phosphatase 2B regulates protein kinase C-alpha activity and endothelial barrier function.

  2001cites this paper
• Effect of Diabetes on Endothelial Function

  2001cites this paper
• The role of protein kinase C in the development of the complications of diabetes.

  2000cites this paper
• Protein kinase C activation and its pharmacological inhibition in vascular disease

  2000cites this paper
• Modification of tight junction function by protein kinase C isoforms.

  2000cites this paper
• G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.

  2000cites this paper
• Serotonin-induced protein kinase C activation in cultured rat heart endothelial cells.

  2000cites this paper
• Delivery of Lipoplexes for Genotherapy of Solid Tumours: Role of Vascular Endothelial Cells

  2000cites this paper
• Involvement of c-Src in diperoxovanadate-induced endothelial cell barrier dysfunction.

  2000cites this paper
• Apoptosis and cell cycle in endothelial cells

  2000cites this paper
• Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?

  1999cites this paper
• Stimulated neutrophils evoke signal transduction to increase vascular permeability in rat lungs.

  1999cites this paper
• Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes.

  1999cites this paper
• Protein kinase C-activated oxidant generation in endothelial cells signals intercellular adhesion molecule-1 gene transcription.

  1999cites this paper
• The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls

  1999cites this paper
• A peptide fraction from factor VIII reduces PKC activity in cultured endothelial cells.

  1998cites this paper
• Protein kinase C β modulates thrombin‐induced Ca2+ signaling and endothelial permeability increase

  1998cites this paper
• Protein kinase C activation and the development of diabetic complications.

  1998cites this paper
• Protein kinase Cβ regulates heterologous desensitization of thrombin receptor (PAR-1) in endothelial cells.

  1998cites this paper
• Decreased protein kinase C activation mediates inhibitory effect of norathyriol on serotonin-mediated endothelial permeability.

  1998cites this paper
• Control of vascular smooth muscle and endothelial cell proliferation and its implication in cardiovascular disease.

  1998cites this paper
• Protein kinase C isoforms in human aortic smooth muscle cells.

  1998cites this paper
• The Role of Protein Kinase C Activation in the Development of Diabetic Vascular Complications

  1998cites this paper
• Site-specific thrombin receptor antibodies inhibit Ca2+ signaling and increased endothelial permeability.

  1997cites this paper
• Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells.

  1997cites this paper
• Site-specific thrombin receptor antibodies inhibit Ca2+ signaling and increased endothelial permeability.

  1997cites this paper
• Enhancement of Migration by Protein Kinase Cα and Inhibition of Proliferation and Cell Cycle Progression by Protein Kinase Cδ in Capillary Endothelial Cells*

  1997cites this paper
• Endothelial Permeability for Macromolecules Mechanistic Aspects of Pathophysiological Modulation

  1997cites this paper
• Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus

  1997cites this paper
• Protein Kinase C-α Activity Modulates Transepithelial Permeability and Cell Junctions in the LLC-PK1 Epithelial Cell Line*

  1997cites this paper
• Inhibitory effect of 2-phenyl-4-quinolone on serotonin-mediated changes in the morphology and permeability of endothelial monolayers.

  1997cites this paper